PhantomGI logo

Making Ostomy
Minimally Invasive

Single access Ostomy, measuring recovery in days, not weeks.
Starting with inoperable patients, built to replace the standard of care.

01Start with the inoperable→
02Expand indications→
03Redefine the standard
01 · The SURGICAL Challenge

Ostomy still
requires surgery

For patients requiring bowel diversion or decompression, ostomy creation requires surgery under general anesthesia.

$70,000
Healthcare Costs

Up to $70k in total cost of care per surgical ostomy case.

55,000*
Inoperable Patients

Up to 55k high-risk and frail patients per year where surgery is not an option.

10 days
Average Hospitalization

According to current CMS reporting.

*per annum, US only

02 · MINIMALLY INVASIVE SURGERY

A Percutaneous Approach
to Ostomy

PercStoma is designed to create an ostomy through a single access point, using a patent pending fixation device and proprietary stent.

Access

The stent delivery system is introduced through the abdominal wall into the bowel using fluoroscopy.

Deploy

The internal stent skirt is deployed in the bowel, followed by the external one.

Stoma

A safe and patent artificial cannula is created, forming an ostomy prosthesis.

1 single
Needle Access Site
2 minutes
Ostomy Reversal
3 days
Time to Discharge
20 minutes
Procedure Time
Patent Pending
03 · VISION

A New Standard
for Ostomy

Phantom GI is starting with patients who cannot undergo surgery. The broader ambition is to establish minimally invasive ostomy creation as an alternative to surgical ostomy across indications — achieving the same clinical objective with significantly less intervention.

Too Sick for Surgery

55k patients · metastatic disease · high anesthetic risk

With no current treatment option for these patients, they suffer a grim prognosis measured in weeks.

Surgical Candidates

Up to 100k patients · bowel resection · diverting ostomy

Patients currently undergoing surgical diverting ostomies can access a safer and cleaner treatment, with half the healthcare costs.

Not Sick Enough for Surgery

Up to 100k patients · IBD · pseudo-obstruction · diverticulitis

Patients who currently aren't considered for ostomy due to the invasive nature of surgery can finally be treated with a minimally invasive approach.

04 · Team

Built By Experts 
MedTech, Radiology & Surgery

Ido Sadan

Ido Sadan

M.Sc
Chief Executive Officer

Expert in minimally invasive medical devices.

Eran Shlomovitz

Eran Shlomovitz

MD
Chief Medical Officer

Surgeon and radiologist with deep clinical expertise.

Eli Bekhor

Eli Bekhor

MD
Chief Scientific Officer

Physician with extensive startup experience.

Medical Advisory Board
Lee L. Swanstrom

Lee L. Swanstrom

MD
KOL Advisor

Pioneer of minimally invasive surgery. Former SAGES President. 350+ publications.

To Be Announced

KOL Advisor

A distinguished medical advisor will be joining the board soon.

05 · Investors & Supporters

Backed By
Pioneers

Under Embargo
Supported By
Israel Innovation Authority

Israel Innovation Authority

The strategic engine behind Israel's globally renowned tech ecosystem.

University Health Network

University Health Network

Toronto, Canada

Canada's largest research and teaching hospital network, advancing clinical innovation.

06 · Connect

Interested in
PercStoma?

Phantom GI is engaging clinicians, investigators, clinical centers, strategic partners and investors as PercStoma advances toward clinical evaluation.

PhantomGI logo

Inventing percutaneous surgery. The world's first minimally invasive, reversible ostomy device.

Navigate

PercStoma™ is an investigational device not yet cleared by any regulatory authority. This site is for informational purposes only, is not a prospectus under the Israeli Securities Law, and does not constitute medical advice or an offer of securities. See our Privacy Policy and Terms of Use for full details.

© 2026 PhantomGI Ltd. All rights reserved.